Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05644002 · ClinicalTrials.gov registry record · NA

Puff Biofeedback to Reduce Smoking Reinforcement

A NA study, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
154
Enrollment target

NCT05644002: Completed NA study, sponsored by Rutgers, The State University of New Jersey.

NCT05644002 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 154 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05644002, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
154 participants
Enrollment target

Study Summary

The purpose of the study is to examine the effects of a novel bio-behavioral paradigm, entitled, Puff Topography Biofeedback Training, compared to a control condition, in reducing stress-induced smoking reinforcement.

Primary Outcome

The Short-Cigarette Purchase Task (CPT) will be used to assess smoking reinforcement in response to stress-precipitated smoking. The CPT is based on progressive-ratio operant schedules wherein participants self-report their hypothetical cigarette consumption at various levels of price. Hypothetical purchasing will be based on the "last cigarette smoked". Five key behavioral economic indices of demand can be obtained from the CPT. One index reported here is the Omax, which is the number of cigare

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Puff Topography Biofeedback Training

Trial Details

FieldValue
Enrollment Target 154 participants
Start Date 2022-03-21
Est. Completion 2023-09-13
Phase NA

What the finished NCT05644002 record still lists

NCT05644002 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT05644002 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05644002 about?

NCT05644002 is a clinical study titled "Puff Biofeedback to Reduce Smoking Reinforcement". The purpose of the study is to examine the effects of a novel bio-behavioral paradigm, entitled, Puff Topography Biofeedback Training, compared to a control condition, in reducing stress-induced smoking reinforcement.

What is the current status of trial NCT05644002?

This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2022-03-21. Estimated completion is 2023-09-13.

What interventions are being tested in trial NCT05644002?

The interventions under investigation include: Control (BEHAVIORAL), Puff Topography Biofeedback Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05644002?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05644002's enrollment target sits among peer trials

154 656th of 2000 higher than 1,345 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04300998 · 154 participants

    Study of CAR-T Therapy in Older Patients

  • NCT04597372 · 154 participants · Phase 2

    Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

  • NCT05294042 · 154 participants · NA

    Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities

  • NCT05512390 · 154 participants · Phase 1

    A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05644002, the US trial registry maintained by the National Library of Medicine. NCT05644002 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.